These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 11854183)

  • 21. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
    Beignon AS; Briand JP; Muller S; Partidos CD
    Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
    Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
    J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
    Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
    Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
    Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
    Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intramuscularly Administered Enterotoxigenic
    Upadhyay I; Lauder KL; Li S; Ptacek G; Zhang W
    Microbiol Spectr; 2022 Aug; 10(4):e0147322. PubMed ID: 35762781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
    You J; Xu Y; He M; McAllister TA; Thacker PA; Li X; Wang T; Jin L
    Appl Microbiol Biotechnol; 2011 Mar; 89(6):1885-93. PubMed ID: 21085949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
    Byrd W; Cassels FJ
    Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
    Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
    Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
    Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
    Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic
    Upadhyay I; Parvej SMD; Shen Y; Li S; Lauder KL; Zhang C; Zhang W
    Infect Immun; 2023 Nov; 91(11):e0027223. PubMed ID: 37874163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
    Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
    Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic
    Zhang C; Li S; Upadhyay I; Lauder KL; Sack DA; Zhang W
    Microbiol Spectr; 2024 Apr; 12(4):e0415323. PubMed ID: 38364078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
    Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J
    Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
    Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
    Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Multivalent Enterotoxigenic
    Seo H; Duan Q; Upadhyay I; Zhang W
    Appl Environ Microbiol; 2022 Sep; 88(17):e0095922. PubMed ID: 35972240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
    Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
    Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.